ABSTRACT
In this study, with a psychodiagnostic survey, we wanted to evaluate the possible presence of depressive symptoms in patients diagnosed with type 2 diabetes. The sample of 106 type 2 diabetic patients consisted of three groups. Group A of 80 patients interviewed in 2017 at the Olbia clinic, group A-1 (a subgroup of A), of 41 patients with a follow-up after 5 years from the first examination in 2017 and group B of 26 new type 2 diabetic patients examined for the first time in 2022. All subject underwent an interview and and have completed the following validated questionnaires: Questionnaire for Mood Disorders (MDQ), Hamilton Psychiatric Rating Scale for Depression (HAM-D), Montgomery-Asberg Scale for Depression (MADRS), Hamilton Anxiety Scale (HAR -S) and Clinical Global Impression (CGI). The objective of the follow-up was to evaluate the possible emotional impact of the COVID-19 pandemic. The aim of the research is to evaluate the correlation between any depressive symptoms and diabetes.